Pre-Annual General Meeting Information • May 4, 2021
Pre-Annual General Meeting Information
Open in ViewerOpens in native device viewer

a Limited Liability Company (Société Anonyme) with a share capital of €169,881,910 registered office: 43 quai de Grenelle -75015 Paris - France 562 008 151 R.C.S Paris
_______________________________________
Paris, May 4, 2021
In accordance with the provisions of articles L. 22-10-62 et seq. of the French Commercial Code, Regulation (EU) No. 596/2014 of the European Parliament and of the Council of April 16, 2014 on market abuse, and articles 241-1 to 241-7 of the French Market Authority's General Regulations, the purpose of this description is to set forth the objectives and the terms of the share buyback program of Imerys (the "Company") that will be submitted to the approval of the Ordinary and Extraordinary Shareholders' Meeting on May 10, 2021 (resolution 13 - Purchase by the Company of its own shares).
As of April 30, 2021:
The Company does not use derivatives with respect to its share buyback programs.
Under the share buyback program approved by the Ordinary and Extraordinary Shareholders' Meeting of May 4, 2020, a new AMAFI liquidity contract was concluded with Exane with effect from April 12, 2021, as the liquidity contract concluded with Rothschild was terminated with effect from March 31, 2021. It is noted that the purchase authorization granted to an investment services firm on July 26, 2019, expired on July 24, 2020.
Among the 214,954 treasury shares held as of April 30, 2021:
The objectives of the program intend to enable the Company to purchase its own shares mainly for the purpose of:
● Maximum proportion of the share capital likely to be purchased - characteristics of the shares
The maximum number of shares that might be bought back is 8,494,095, representing 10% of the shares existing and outstanding as of January 1, 2021.
The shares that are concerned by the share buyback are the Imerys shares listed on NYSE Euronext Paris stock exchange (ISIN code FR0000120859).
The maximum purchase price would be €85 per share.
The maximum total investment devoted to these acquisitions would be € 721,998,075.
Acquisitions will be carried out on the market or OTC (over-the-counter) market by any means, including the transfer of blocks and the use of any financial product and derivatives, and at all times except during periods of public offers for the Company's shares.
It is proposed to the Ordinary and Extraordinary Shareholders' Meeting on May 10, 2021 to set the term of the present program at eighteen months from the date of the General Meeting, i.e. until November 9, 2022.
The present description was submitted to the French Financial Markets Authority. It is available at the Company's head office, 43 quai de Grenelle, 75015 Paris (France) and on the Company's website (https://www.imerys.com/finance/finance/publications-regulated-information).
____________________
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.